N-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N,N-dimethyl-2-[10-oxo-13-[4-[(2,2,2-trifluoroethylamino)methyl]cyclohexyl]-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-11-yl]acetamide;N-[[4-(11-ethyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-methyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N-methyl-N-[[4-[10-oxo-11-(2,2,2-trifluoroethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl]cyclohexyl]methyl]methanesulfonamide

C133H181F6N35O13S3 — CID 159867522

IUPACN-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N,N-dimethyl-2-[10-oxo-13-[4-[(2,2,2-trifluoroethylamino)methyl]cyclohexyl]-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-11-yl]acetamide;N-[[4-(11-ethyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-methyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N-methyl-N-[[4-[10-oxo-11-(2,2,2-trifluoroethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl]cyclohexyl]methyl]methanesulfonamide
SMILESCCN1CN(C2CCC(CN(C)S(C)(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O.CN(C)C(=O)CN1CN(C2CCC(CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O.CN(CC1CCC(N2CN(C3CC3)C(=O)c3cnc4[nH]ccc4c32)CC1)S(C)(=O)=O.CN(CC1CCC(N2CN(CC(F)(F)F)C(=O)c3cnc4[nH]ccc4c32)CC1)S(C)(=O)=O.CN1CN(C2CCC(CN3CCN(CCC#N)CC3)CC2)c2c(cnc3[nH]ccc23)C1=O.N#CCCN1CCN(CC2CCC(N3CN(C4CC4)C(=O)c4cnc5[nH]ccc5c43)CC2)CC1
InChIInChI=1S/C26H35N7O.C24H33N7O.C22H29F3N6O2.C21H29N5O3S.C20H26F3N5O3S.C20H29N5O3S/c27-9-1-11-30-12-14-31(15-13-30)17-19-2-4-20(5-3-19)32-18-33(21-6-7-21)26(34)23-16-29-25-22(24(23)32)8-10-28-25;1-28-17-31(22-20-7-9-26-23(20)27-15-21(22)24(28)32)19-5-3-18(4-6-19)16-30-13-11-29(12-14-30)10-2-8-25;1-29(2)18(32)11-30-13-31(15-5-3-14(4-6-15)9-26-12-22(23,24)25)19-16-7-8-27-20(16)28-10-17(19)21(30)33;1-24(30(2,28)29)12-14-3-5-15(6-4-14)25-13-26(16-7-8-16)21(27)18-11-23-20-17(19(18)25)9-10-22-20;1-26(32(2,30)31)10-13-3-5-14(6-4-13)28-12-27(11-20(21,22)23)19(29)16-9-25-18-15(17(16)28)7-8-24-18;1-4-24-13-25(15-7-5-14(6-8-15)12-23(2)29(3,27)28)18-16-9-10-21-19(16)22-11-17(18)20(24)26/h8,10,16,19-21H,1-7,11-15,17-18H2,(H,28,29);7,9,15,18-19H,2-6,10-14,16-17H2,1H3,(H,26,27);7-8,10,14-15,26H,3-6,9,11-13H2,1-2H3,(H,27,28);9-11,14-16H,3-8,12-13H2,1-2H3,(H,22,23);7-9,13-14H,3-6,10-12H2,1-2H3,(H,24,25);9-11,14-15H,4-8,12-13H2,1-3H3,(H,21,22)
InChIKeyNRXPIFGHHMZNDI-UHFFFAOYSA-N
MW2688.33 g/mol
LogP15.56
Rot. Bonds32

About N-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N,N-dimethyl-2-[10-oxo-13-[4-[(2,2,2-trifluoroethylamino)methyl]cyclohexyl]-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-11-yl]acetamide;N-[[4-(11-ethyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-methyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N-methyl-N-[[4-[10-oxo-11-(2,2,2-trifluoroethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl]cyclohexyl]methyl]methanesulfonamide

N-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N,N-dimethyl-2-[10-oxo-13-[4-[(2,2,2-trifluoroethylamino)methyl]cyclohexyl]-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-11-yl]acetamide;N-[[4-(11-ethyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-methyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N-methyl-N-[[4-[10-oxo-11-(2,2,2-trifluoroethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl]cyclohexyl]methyl]methanesulfonamide (PubChem CID 159867522) has the molecular formula C133H181F6N35O13S3 and a molecular weight of 2688.33 g/mol. Its IUPAC name is N-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N,N-dimethyl-2-[10-oxo-13-[4-[(2,2,2-trifluoroethylamino)methyl]cyclohexyl]-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-11-yl]acetamide;N-[[4-(11-ethyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-methyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N-methyl-N-[[4-[10-oxo-11-(2,2,2-trifluoroethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl]cyclohexyl]methyl]methanesulfonamide.

Molecular Properties

Compound NameN-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N,N-dimethyl-2-[10-oxo-13-[4-[(2,2,2-trifluoroethylamino)methyl]cyclohexyl]-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-11-yl]acetamide;N-[[4-(11-ethyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-methyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N-methyl-N-[[4-[10-oxo-11-(2,2,2-trifluoroethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl]cyclohexyl]methyl]methanesulfonamide
PubChem CID159867522
Molecular FormulaC133H181F6N35O13S3
Molecular Weight2688.33 g/mol
Exact Mass2686.36
IUPAC NameN-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N,N-dimethyl-2-[10-oxo-13-[4-[(2,2,2-trifluoroethylamino)methyl]cyclohexyl]-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-11-yl]acetamide;N-[[4-(11-ethyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-methyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N-methyl-N-[[4-[10-oxo-11-(2,2,2-trifluoroethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl]cyclohexyl]methyl]methanesulfonamide
SMILESCCN1CN(C2CCC(CN(C)S(C)(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O.CN(C)C(=O)CN1CN(C2CCC(CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O.CN(CC1CCC(N2CN(C3CC3)C(=O)c3cnc4[nH]ccc4c32)CC1)S(C)(=O)=O.CN(CC1CCC(N2CN(CC(F)(F)F)C(=O)c3cnc4[nH]ccc4c32)CC1)S(C)(=O)=O.CN1CN(C2CCC(CN3CCN(CCC#N)CC3)CC2)c2c(cnc3[nH]ccc23)C1=O.N#CCCN1CCN(CC2CCC(N3CN(C4CC4)C(=O)c4cnc5[nH]ccc5c43)CC2)CC1
InChIInChI=1S/C26H35N7O.C24H33N7O.C22H29F3N6O2.C21H29N5O3S.C20H26F3N5O3S.C20H29N5O3S/c27-9-1-11-30-12-14-31(15-13-30)17-19-2-4-20(5-3-19)32-18-33(21-6-7-21)26(34)23-16-29-25-22(24(23)32)8-10-28-25;1-28-17-31(22-20-7-9-26-23(20)27-15-21(22)24(28)32)19-5-3-18(4-6-19)16-30-13-11-29(12-14-30)10-2-8-25;1-29(2)18(32)11-30-13-31(15-5-3-14(4-6-15)9-26-12-22(23,24)25)19-16-7-8-27-20(16)28-10-17(19)21(30)33;1-24(30(2,28)29)12-14-3-5-15(6-4-14)25-13-26(16-7-8-16)21(27)18-11-23-20-17(19(18)25)9-10-22-20;1-26(32(2,30)31)10-13-3-5-14(6-4-13)28-12-27(11-20(21,22)23)19(29)16-9-25-18-15(17(16)28)7-8-24-18;1-4-24-13-25(15-7-5-14(6-8-15)12-23(2)29(3,27)28)18-16-9-10-21-19(16)22-11-17(18)20(24)26/h8,10,16,19-21H,1-7,11-15,17-18H2,(H,28,29);7,9,15,18-19H,2-6,10-14,16-17H2,1H3,(H,26,27);7-8,10,14-15,26H,3-6,9,11-13H2,1-2H3,(H,27,28);9-11,14-16H,3-8,12-13H2,1-2H3,(H,22,23);7-9,13-14H,3-6,10-12H2,1-2H3,(H,24,25);9-11,14-15H,4-8,12-13H2,1-3H3,(H,21,22)
InChIKeyNRXPIFGHHMZNDI-UHFFFAOYSA-N
XLogP15.56
TPSA518.40 Ų
H-Bond Donors7
H-Bond Acceptors32
Rotatable Bonds32
Heavy Atoms190
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002688.33
LogP ≤ 515.56
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1032

Analyze N-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N,N-dimethyl-2-[10-oxo-13-[4-[(2,2,2-trifluoroethylamino)methyl]cyclohexyl]-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-11-yl]acetamide;N-[[4-(11-ethyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-methyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N-methyl-N-[[4-[10-oxo-11-(2,2,2-trifluoroethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl]cyclohexyl]methyl]methanesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N,N-dimethyl-2-[10-oxo-13-[4-[(2,2,2-trifluoroethylamino)methyl]cyclohexyl]-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-11-yl]acetamide;N-[[4-(11-ethyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-methyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N-methyl-N-[[4-[10-oxo-11-(2,2,2-trifluoroethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl]cyclohexyl]methyl]methanesulfonamide?
The IUPAC name of N-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N,N-dimethyl-2-[10-oxo-13-[4-[(2,2,2-trifluoroethylamino)methyl]cyclohexyl]-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-11-yl]acetamide;N-[[4-(11-ethyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-methyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N-methyl-N-[[4-[10-oxo-11-(2,2,2-trifluoroethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl]cyclohexyl]methyl]methanesulfonamide (CID 159867522) is N-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N,N-dimethyl-2-[10-oxo-13-[4-[(2,2,2-trifluoroethylamino)methyl]cyclohexyl]-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-11-yl]acetamide;N-[[4-(11-ethyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-methyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N-methyl-N-[[4-[10-oxo-11-(2,2,2-trifluoroethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl]cyclohexyl]methyl]methanesulfonamide.
What is the SMILES notation for N-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N,N-dimethyl-2-[10-oxo-13-[4-[(2,2,2-trifluoroethylamino)methyl]cyclohexyl]-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-11-yl]acetamide;N-[[4-(11-ethyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-methyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N-methyl-N-[[4-[10-oxo-11-(2,2,2-trifluoroethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl]cyclohexyl]methyl]methanesulfonamide?
The canonical SMILES for N-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N,N-dimethyl-2-[10-oxo-13-[4-[(2,2,2-trifluoroethylamino)methyl]cyclohexyl]-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-11-yl]acetamide;N-[[4-(11-ethyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-methyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N-methyl-N-[[4-[10-oxo-11-(2,2,2-trifluoroethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl]cyclohexyl]methyl]methanesulfonamide is CCN1CN(C2CCC(CN(C)S(C)(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O.CN(C)C(=O)CN1CN(C2CCC(CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O.CN(CC1CCC(N2CN(C3CC3)C(=O)c3cnc4[nH]ccc4c32)CC1)S(C)(=O)=O.CN(CC1CCC(N2CN(CC(F)(F)F)C(=O)c3cnc4[nH]ccc4c32)CC1)S(C)(=O)=O.CN1CN(C2CCC(CN3CCN(CCC#N)CC3)CC2)c2c(cnc3[nH]ccc23)C1=O.N#CCCN1CCN(CC2CCC(N3CN(C4CC4)C(=O)c4cnc5[nH]ccc5c43)CC2)CC1.
What is the InChIKey of N-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N,N-dimethyl-2-[10-oxo-13-[4-[(2,2,2-trifluoroethylamino)methyl]cyclohexyl]-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-11-yl]acetamide;N-[[4-(11-ethyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-methyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N-methyl-N-[[4-[10-oxo-11-(2,2,2-trifluoroethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl]cyclohexyl]methyl]methanesulfonamide?
The InChIKey is NRXPIFGHHMZNDI-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H35N7O.C24H33N7O.C22H29F3N6O2.C21H29N5O3S.C20H26F3N5O3S.C20H29N5O3S/c27-9-1-11-30-12-14-31(15-13-30)17-19-2-4-20(5-3-19)32-18-33(21-6-7-21)26(34)23-16-29-25-22(24(23)32)8-10-28-25;1-28-17-31(22-20-7-9-26-23(20)27-15-21(22)24(28)32)19-5-3-18(4-6-19)16-30-13-11-29(12-14-30)10-2-8-25;1-29(2)18(32)11-30-13-31(15-5-3-14(4-6-15)9-26-12-22(23,24)25)19-16-7-8-27-20(16)28-10-17(19)21(30)33;1-24(30(2,28)29)12-14-3-5-15(6-4-14)25-13-26(16-7-8-16)21(27)18-11-23-20-17(19(18)25)9-10-22-20;1-26(32(2,30)31)10-13-3-5-14(6-4-13)28-12-27(11-20(21,22)23)19(29)16-9-25-18-15(17(16)28)7-8-24-18;1-4-24-13-25(15-7-5-14(6-8-15)12-23(2)29(3,27)28)18-16-9-10-21-19(16)22-11-17(18)20(24)26/h8,10,16,19-21H,1-7,11-15,17-18H2,(H,28,29);7,9,15,18-19H,2-6,10-14,16-17H2,1H3,(H,26,27);7-8,10,14-15,26H,3-6,9,11-13H2,1-2H3,(H,27,28);9-11,14-16H,3-8,12-13H2,1-2H3,(H,22,23);7-9,13-14H,3-6,10-12H2,1-2H3,(H,24,25);9-11,14-15H,4-8,12-13H2,1-3H3,(H,21,22).
What are the key properties of N-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N,N-dimethyl-2-[10-oxo-13-[4-[(2,2,2-trifluoroethylamino)methyl]cyclohexyl]-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-11-yl]acetamide;N-[[4-(11-ethyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-methyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N-methyl-N-[[4-[10-oxo-11-(2,2,2-trifluoroethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl]cyclohexyl]methyl]methanesulfonamide?
N-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N,N-dimethyl-2-[10-oxo-13-[4-[(2,2,2-trifluoroethylamino)methyl]cyclohexyl]-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-11-yl]acetamide;N-[[4-(11-ethyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-methyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N-methyl-N-[[4-[10-oxo-11-(2,2,2-trifluoroethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl]cyclohexyl]methyl]methanesulfonamide has a molecular weight of 2688.33 g/mol, XLogP of 15.56, 32 rotatable bonds, 7 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-cyclopropyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N,N-dimethyl-2-[10-oxo-13-[4-[(2,2,2-trifluoroethylamino)methyl]cyclohexyl]-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-11-yl]acetamide;N-[[4-(11-ethyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]-N-methylmethanesulfonamide;3-[4-[[4-(11-methyl-10-oxo-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl)cyclohexyl]methyl]piperazin-1-yl]propanenitrile;N-methyl-N-[[4-[10-oxo-11-(2,2,2-trifluoroethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-13-yl]cyclohexyl]methyl]methanesulfonamide is sourced from PubChem (CID 159867522), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).